D
David J. Margolis
Researcher at University of Pennsylvania
Publications - 581
Citations - 74527
David J. Margolis is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Population & Atopic dermatitis. The author has an hindex of 97, co-authored 521 publications receiving 62556 citations. Previous affiliations of David J. Margolis include Rutgers University & Harvard University.
Papers
More filters
Les aides sociales et l’offre de travail : Y a-t-il une trappe à inactivité ?
TL;DR: In this article, the authors consider the relevance of the argument that generous welfare payments can induce an "inactivity trap" (where people prefer to remain outside of the labor market, subsisting on transfer payments, than to look for paid employment).
Posted Content
Moduler les cotisations employeurs à l'assurance - chômage: Le système américain de l'experience rating
Denis Fougère,David J. Margolis +1 more
TL;DR: Experience rating as discussed by the authors is a règle de modulation, appelée "experience rating", designed to support the cotisations patronales à l'assurance chômage.
Journal Article
Cost Effectiveness of Fish Skin Grafts Versus Standard of Care on Wound Healing of Chronic Diabetic Foot Ulcers: A Retrospective Comparative Cohort Study
TL;DR: In this article, the authors evaluated the cost effectiveness of fish skin therapy compared with standard of care (SOC) on chronic diabetic foot ulcers (DFUs) and concluded that the fish skin treatment (on DFUs) would be 93.6% likely to be cost effective for a willingness to pay at $100 000 per QALY and 71.4% likelihood to be cheaper than SOC.
Journal ArticleDOI
Altered Response Pattern following AZD5582 Treatment of SIV-Infected, ART-Suppressed Rhesus Macaque Infants
Katherine M. Bricker,Veronica Obregon-Perko,Brianna Williams,Danielle Oliver,Ferzan Uddin,Margaret Neja,Louis Hopkins,Amir Dashti,Sherrie Jean,Jennifer S. Wood,Stephanie Ehnert,Shan Liang,Thomas H. Vanderford,Gregory K. Tharp,Steven E. Bosinger,Amanda P. Schauer,Maud Mavigner,Mackenzie L. Cottrell,David J. Margolis,Richard M. Dunham,Ann Chahroudi +20 more
TL;DR: The results suggest that dosing modifications for this latency reversal approach may be necessary to maximize virus reactivation in the pediatric setting for successful “shock and kill” strategies.